Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.00
Bid: 77.10
Ask: 78.30
Change: 0.00 (0.00%)
Spread: 1.20 (1.556%)
Open: 77.00
High: 77.00
Low: 77.00
Prev. Close: 77.00
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Issue of Equity

18 Sep 2013 09:31

RNS Number : 2865O
GCP Infrastructure Investments Ltd
18 September 2013
 



18 September 2013

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, DISTRIBUTION OR PUBLICATION IS OR WOULD BE UNLAWFUL.

This announcement does not constitute an offer to sell, or the solicitation of an offer to subscribe for or to buy, shares in any jurisdiction.

GCP Infrastructure Investments Limited ("GCP" or the "Company")

Proposed Issue of equity

Following recently-announced investments, the board of Directors (the "Board") of GCP Infrastructure Investments Limited is pleased to announce that the Company is seeking to raise up to £22 million before costs through the issue of ordinary shares in the capital of the Company ("Shares") by way of tap issuance to selected investors (the "Issue") through its corporate broker, Oriel Securities Limited ("Oriel"). 

The Issue price is expected to be set at 107.75p and the Issue is expected to close by 12:30pm (London time) on 20 September 2013. However the Issue price and the closing date may be altered at the absolute discretion of the Company and Oriel. The decision to allot Shares to any investor shall be at the absolute discretion of the Company and Oriel.

The Company has the authority to issue up to 26,483,400 million Shares on a non pre-emptive basis as and when the Board deems appropriate. The Board now deems it appropriate to issue shares based on the good pipeline of investment opportunities of the Master Fund (as defined below) as well as the premium at which the Company's Shares trade relative to the Net Asset Value per Share.

The Company will make a further announcement of the results of the Issue when it has completed.

 

Contact details:

 

 

 

 

Gravis Capital Partners LLP

 

Stephen Ellis

+44 (0)20 7518 1495

Rollo Wright

+44 (0)20 7518 1493

 

 

 

Oriel Securities

 

Neil Winward

+44 (0)20 7710 7600

Mark Bloomfield

 

Tunga Chigovanyika

 

 

 

 

 

 

 

Buchanan

 

Charles Ryland

+44 (0)20 7466 5000

Sophie McNulty

 

 

 

 

Notes to Editors

The Company

The Company is a closed-ended investment company that seeks to generate returns from senior and subordinated infrastructure debt and related and/or similar assets (the "Target Assets"). The Company achieves this by investing substantially all of its capital in GCP Infrastructure Fund Limited (the "Master Fund"), an open-ended investment company that holds the Target Assets. The Company is the majority shareholder of the Master Fund. The Company and the Master Fund are advised by Gravis Capital Partners LLP (the "Investment Adviser").

 

IMPORTANT INFORMATION

Prospective investors in the Issue will be selected by the Company and Oriel. Members of the public are not eligible to take part in the Issue and no public offering of securities will be made. Participation by any prospective investor in the Issue and the allocation of Shares pursuant to the Issue shall be at the absolute discretion of Oriel and the Company.

This announcement is directed only at persons who are: (a) persons outside the European Economic Area to whom it is lawful to communicate this announcement and (b) persons in member states of the European Economic Area who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive ("Qualified Investors"). For the purposes of this provision, the expression "Prospectus Directive" means Directive 2003/71/EC and includes any relevant implementing measure in each member state of the European Economic Area which has implemented the Prospectus Directive. In addition, in the United Kingdom, this announcement is directed only at Qualified Investors (i) who have professional experience in matters relating to investments who fall within the definition of "investment professional" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) who are high net worth companies, unincorporated associations, partnerships or trustees of high value trusts as described in Article 49(2) of the Order.

This announcement and the information contained herein is not for publication, release or distribution, directly or indirectly, in or into the United States, Australia, Canada or Japan or any jurisdiction in which the same would be unlawful. This announcement does not constitute an offer to sell or issue or the solicitation of an offer to buy or acquire shares in the capital of the Company.

The Shares issued and/or to be issued by the Company pursuant to the Issue (the "Securities") have not been and will not be registered under the US Securities Act of 1933 (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States. The Securities may not be offered, sold, resold, pledged, delivered, distributed or otherwise transferred, directly or indirectly, into or within the United States, or to, or for the account or benefit of, US persons (as defined in Regulation S under the Securities Act). No public offering of the Securities is being made in the United States. The Company has not been and will not be registered under the US Investment Company Act of 1940 (the "Investment Company Act") and, as such, holders of the Securities will not be entitled to the benefits of the Investment Company Act.

No information contained in this announcement should be taken as constituting an offer to the public in Jersey for the purposes of the Control of Borrowing (Jersey) Order 1958 or the Collective Investment Funds (Jersey) Law 1988. This announcement is directed only at persons who fall within the definition of "eligible investor" as set out in the Collective Investment Funds (Unregulated Funds) (Jersey) Order 2008.

Oriel, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting for the Company and is acting for no-one else in connection with the Issue.

All investments are subject to risk, including the loss of the principal amount invested. Past performance is no guarantee of future returns. You should always seek expert legal, financial, tax and other professional advice before making any investment decision.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUWUWROKAKARR
Date   Source Headline
8th Jun 20219:47 amRNSAdditional Listing and Total Voting Rights
28th May 20219:23 amRNSAdditional Listing
13th May 20217:00 amRNSScrip Share Reference Price
30th Apr 20217:00 amRNSInvestor Report at 31 March 2021
21st Apr 202111:06 amRNSDividend Declaration & Scrip Dividend Alternative
19th Apr 20217:00 amRNSNet Asset Value(s)
31st Mar 20217:00 amRNSTotal Voting Rights
30th Mar 20217:00 amRNSRevolving Credit Facility
22nd Mar 20211:08 pmRNSNew Directorship Notification
12th Mar 20211:29 pmRNSHolding(s) in Company
9th Mar 20214:26 pmRNSDirector/PDMR Shareholding
9th Mar 20219:08 amRNSAdditional Listing and Total Voting Rights
26th Feb 20219:39 amRNSAdditional Listing
11th Feb 20217:00 amRNSScrip Share Reference Price
10th Feb 202112:50 pmRNSDirectorate Change
10th Feb 202112:49 pmRNSResult of AGM
27th Jan 20217:00 amRNSInvestor Report at 31 December 2020
22nd Jan 202111:54 amRNSDividend Declaration & Scrip Dividend Alternative
18th Jan 20217:00 amRNSNet Asset Value(s)
11th Jan 202110:31 amRNSUpdate research from QuotedData
8th Jan 20219:00 amRNSNotice of AGM Circular
31st Dec 20207:00 amRNSTotal Voting Rights
17th Dec 20207:00 amRNSAnnual report and financial statements
7th Dec 202012:37 pmRNSDirector/PDMR Shareholding
7th Dec 20209:13 amRNSAdditional Listing and Total Voting Rights
4th Dec 20207:00 amRNSInvestment Adviser strategic partnership
27th Nov 20207:00 amRNSAdditional Listing
12th Nov 20207:00 amRNSScrip Share Reference Price
30th Oct 20207:00 amRNSInvestor Report as at 30 September 2020
23rd Oct 202011:42 amRNSDividend Declaration & Scrip Dividend Alternative
23rd Oct 202010:41 amRNSDividend Declaration & Script Dividend Alternative
16th Oct 20207:00 amRNSNet Asset Value(s)
12th Oct 20207:00 amRNSGreen Economy Mark
3rd Sep 202012:50 pmRNSDirector/PDMR Shareholding
28th Aug 20209:56 amRNSAdditional Listing and Total Voting Rights
21st Aug 202012:54 pmRNSAdditional Listing
6th Aug 20207:00 amRNSScrip Share Reference Price
30th Jul 20207:00 amRNSInvestor Report as at 30 June 2020
28th Jul 20201:19 pmRNSNotification of Major Holdings
23rd Jul 202010:42 amRNSDividend Declaration & Scrip Dividend Alternative
15th Jul 20207:00 amRNSNet Asset Value(s)
30th Jun 20207:00 amRNSTotal Voting Rights
10th Jun 20205:35 pmRNSDirector/PDMR Shareholding
10th Jun 202012:04 pmRNSAdditional Listing and Total Voting Rights
3rd Jun 20207:00 amRNSAdditional Listing
1st Jun 20201:48 pmRNSUpdate research from QuotedData
29th May 20207:00 amRNSHalf-yearly Report and Financial Statements 2020
15th May 20207:00 amRNSScrip Share Reference Price
1st May 20207:00 amRNSInvestor Report as at 31 March 2020
24th Apr 202011:16 amRNSDividend Declaration & Scrip Dividend Alternative

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.